Critical Diagnostics Critical Diagnostics
Critical Diagnostics was founded in 2004 and is focused on the discovery, development, and commercialization of novel biomarkers in cardiovascular diseases . The lead product, the PresageĀ® ST2 Assay , has received FDA clearance and is CE Marked in Europe. This simple, non-invasive test measures for soluble ST2 in the blood, which can aid physicians in risk assessment of heart failure...   Read More
Close filters
from to
Aspect Reader
Aspect Reader
Heart failure progresses primarily through fibrosis and adverse remodeling as a result of cardiac injury or stress. ST2 is a biomarker that, unlike natriuretic peptides or troponin, uniquely reflects this pathway. ST2 changes rapidly...
CHF5,750.00 *